CDXS

Codexis, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$0.96

Price (1 Year)

$2.85 $0.96

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %18.9 / %30
Non-compliant assets / Total market cap %22.5 / %30
Non-compliant revenue / Total income %3.8 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.

Website

Analysis (Turkish): CDXS Hissesi Caiz mi, Helal mi? Codexis, Inc. Katılım Analizi